Humanity is living in an interesting age, where scientists can finally start manipulating the human genome in ways that were not possible before due to CRISPR. Many have even hypothesized that through these amazing gene-editing tool, humans could become stronger, smarter, and all around better. Unfortunately, it could also lead to class warfare, an expert on genetics warns.
Dr. David King is a molecular biologist and is the founder of the watchdog group Human Genetics Alert. In a recent opinion piece published on The Guardian, Dr. King throws some cautious words at readers, warning them about the dangers of a blind race towards medical progress at the cost of everything else.
He is particularly keen on cautioning the public about genetic manipulation, especially when it no longer has anything to do with treating actual conditions. Dr. King explains that there are already plenty of ways to address genetic conditions among infants via early testing.
“Scientists who started their careers hoping to treat sick people and prevent suffering are now earning millions of dollars creating drugs to “enhance cognitive performance” or performing cosmetic surgery. We already have consumer eugenics in the US egg donor market, where ordinary working-class women get paid $5,000 for their eggs while tall, beautiful Ivy League students get $50,000. The free market effectively results in eugenics,” Dr. King writes.
Of course, for every person that shares Dr. King’s concerns, there are those who say that being able to tamper with genetic traits in babies is still a long way off. A researcher from Toronto’s Hospital for Sick Children, Dr. Janet Rossant said as much in another article published by The Guardian. According to her, designer babies are still not in the veil of reality as of right now.
“We are still a long way from serious consideration of using gene editing to enhance traits in babies,” Dr. Rossant explained. “We don’t understand the genetic basis of many of the human traits that might be targets for enhancement.”


Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Tabletop particle accelerator could transform medicine and materials science
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Neuralink Expands Brain Implant Trials with 12 Global Patients
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



